Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.IMGN has closed above bottom band by 23.4%. Bollinger Bands are 85.4% wider than normal. The large width of the bands suggest high volatility as compared to IMGN's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.
2020-02-14 ImmunoGen Beats Expectations and Fuels Optimism for Its Lead Drug Candidate | The Motley Fool Cost-cutting led to a surprise profit, and the company outlined the path ahead for its pipeline treatment for ovarian cancer.
2020-02-14 ImmunoGen (IMGN) Q4 Earnings and Revenues Beat Estimates ImmunoGen (IMGN) delivered earnings and revenue surprises of 160.00% and 53.43%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.